David G. Kalergis
2018
In 2018, David G. Kalergis earned a total compensation of $587.1K as Chief Executive Officer at Diffusion Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $66,208 |
|---|---|
| Option Awards | $64,905 |
| Salary | $439,192 |
| Other | $16,836 |
| Total | $587,141 |
Kalergis received $439.2K in salary, accounting for 75% of the total pay in 2018.
Kalergis also received $66.2K in non-equity incentive plan, $64.9K in option awards and $16.8K in other compensation.
Rankings
In 2018, David G. Kalergis' compensation ranked 11,363rd out of 14,244 executives tracked by ExecPay. In other words, Kalergis earned more than 20.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,363 out of 14,244 | 20th |
Division Manufacturing | 4,596 out of 5,759 | 20th |
Major group Chemicals And Allied Products | 1,740 out of 2,122 | 18th |
Industry group Drugs | 1,478 out of 1,811 | 18th |
Industry Pharmaceutical Preparations | 1,133 out of 1,385 | 18th |
Source: SEC filing on April 30, 2019.
Kalergis' colleagues
We found three more compensation records of executives who worked with David G. Kalergis at Diffusion Pharmaceuticals in 2018.